Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer’s disease

References

• Thies W, Bleiler L. Alzheimer's disease facts and figures. Alzheimer's Dement 2013;9:208–45.
   PubMed Web of Science ®Google Scholar
• Tang H, Zhao HT, Zhong SM, et al. Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. Bioorg Med Chem Lett 2012;22:2257–61.
   PubMed Web of Science ®Google Scholar
• Laferla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 2007;8:499–509.
   PubMed Web of Science ®Google Scholar
• Wilkinson D, Wirth Y, Goebel C. Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response. Dement Geriatr Cogn Disord 2014;37:71–85.
   PubMed Web of Science ®Google Scholar
• Xie Q, Wang H, Xia Z, et al. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation. J Med Chem 2008;51:2027–36.
   PubMed Web of Science ®Google Scholar
• Munoz-Torrero D. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimers disease. Curr Med Chem 2008;15:2433–55.
   PubMed Web of Science ®Google Scholar
• Reyes AE, Chacón MA, Dinamarca MC, et al. Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 2014;164:2163–74.
   Web of Science ®Google Scholar
• Fernández-Bachiller MI, Pérez C, Monjas L, et al. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. J Med Chem 2012;55:1303–17.
   PubMed Web of Science ®Google Scholar
• Özturan Özer E, Tan OU, Ozadali K, et al. Synthesis, molecular modeling and evaluation of novel N′-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation. Bioorg Med Chem Lett 2013;23:440–3.
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353–6.
   PubMed Web of Science ®Google Scholar
• Paul S, Planque S, Nishiyama Y. Beneficial catalytic immunity to abeta peptide. Rejuvenat Res 2010;13:179–87.
   PubMed Web of Science ®Google Scholar
• Bush AI. Drug development based on the metals hypothesis of Alzheimer's disease. J. Alzheimers Dis 2008;15:223–40.
   PubMed Web of Science ®Google Scholar
• Fernández-Bachiller M, Pérez C, González-Muñoz GC, et al. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J Med Chem 2010;53:4927–37.
   PubMed Web of Science ®Google Scholar
• Price KA, Crouch PJ, White AR. Therapeutic treatment of Alzheimer's disease using metal complexing agents. Recent Pat CNS Drug Discov 2007;2:180–7.
   PubMedGoogle Scholar
• Ansari MA, Scheff SW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 2010;69:155–67.
   PubMed Web of Science ®Google Scholar
• Jiang CS, Fu Y, Zhang L, et al. Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents. Bioorg Med Chem Lett 2015;25:216–20.
   PubMed Web of Science ®Google Scholar
• Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem 2005;48:6523–43.
   PubMed Web of Science ®Google Scholar
• León R, Garcia AG, Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. Med Res Rev 2013;33:139–89.
   PubMed Web of Science ®Google Scholar
• Agis-Torres A, Sölhuber M, Fernandez M, et al. Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer's disease. Curr Neuropharmacol 2014;12:2–36.
   PubMed Web of Science ®Google Scholar
• Bukhari SN, Jantan I. Synthetic curcumin analogs as inhibitors of β-amyloid peptide aggregation: potential therapeutic and diagnostic agents for Alzheimer's disease. Mini Rev Med Chem 2015;15:1110–21.
   PubMed Web of Science ®Google Scholar
• Bajda M, Guzior N, Ignasik M, et al. Multi-target-directed ligands in Alzheimer's disease treatment. Curr Med Chem 2011;18:4949–75.
   PubMed Web of Science ®Google Scholar
• Chen X, Decker M. Multi-target compounds acting in the central nervous system designed from natural products. Curr Med Chem 2013;20:1673–85.
   PubMed Web of Science ®Google Scholar
• Sezgin Z, Dincer Y. Alzheimer's disease and epigenetic diet. Neurochem Int 2014;78:105–16.
   PubMed Web of Science ®Google Scholar
• Barone E, Calabrese V, Mancuso C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 2009;10:97–108.
   PubMed Web of Science ®Google Scholar
• Kanski J, Aksenova M, Stoyanova A, et al. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure–activity studies. J Nutr Biochem 2002;13:273–81.
   PubMed Web of Science ®Google Scholar
• Sgarbossa A, Giacomazza D, di Carlo M. Ferulic acid: a hope for Alzheimer's disease therapy from plants. Nutrients 2015;7:5764–82.
   PubMed Web of Science ®Google Scholar
• Maruf AA, Lip H, Wong H, et al. Protective effects of ferulic acid and related polyphenols against glyoxal- or methylglyoxal-induced cytotoxicity and oxidative stress in isolated rat hepatocytes. Chem Biol Interact 2015;234:96–104.
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Yamada M. Review: curcumin and Alzheimer's disease. CNS Neurosci Ther 2015;16:285–97.
   Web of Science ®Google Scholar
• Wang Y, Yin H, Wang L, et al. Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med 2013;41:59–70.
   PubMed Web of Science ®Google Scholar
• Benchekroun M, Bartolini M, Egea J, et al. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids. ChemMedChem 2015;10:523–39.
   PubMed Web of Science ®Google Scholar
• Pan W, Hu K, Bai P, et al. Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2016;26:2539–43.
   PubMed Web of Science ®Google Scholar
• Fang L, Chen M, Liu Z, et al. Ferulic acid-carbazole hybrid compounds: combination of cholinesterase inhibition, antioxidant and neuroprotection as multifunctional anti-Alzheimer agents. Bioorg Med Chem 2016;24:886–93.
   PubMed Web of Science ®Google Scholar
• Xu W, Wang XB, Wang ZM, et al. Synthesis and evaluation of donepezil–ferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease. Med Chem Commun 2016;7:990–8.
   Web of Science ®Google Scholar
• Estrada M, Herrera-Arozamena C, Pérez C, et al. New cinnamic – N-benzylpiperidine and cinnamic – N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties. Eur J Med Chem 2016;121:376–86.
   PubMed Web of Science ®Google Scholar
• Baharloo F, Moslemin MH, Nadri H, et al. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors. Eur J Med Chem 2015;93:196–201.
   PubMed Web of Science ®Google Scholar
• Mostofi M, Mohammadi Ziarani G, Mahdavi M, et al. Synthesis and structure–activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors. Eur J Med Chem 2015;103:361–9.
   PubMed Web of Science ®Google Scholar
• Wang C, Wu Z, Cai H, et al. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors. Bioorg Med Chem Lett 2015;25:5212–16.
   PubMed Web of Science ®Google Scholar
• Lan JS, Xie SS, Li SY, et al. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease. Bioorg Med Chem 2014;22:6089–104.
   PubMed Web of Science ®Google Scholar
• Xie SS, Lan JS, Wang XB, et al. Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties. Eur J Med Chem 2015;93:42–50.
   PubMed Web of Science ®Google Scholar
• Xie SS, Lan JS, Wang X, et al. Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease. Bioorg Med Chem 2016;24:1528–39.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Benek O, Musilek K, Horova A, et al. Preparation, in vitro screening and molecular modelling of monoquaternary compounds related to the selective acetylcholinesterase inhibitor BW284c51. Med Chem 2014;11:21–9.
   PubMed Web of Science ®Google Scholar
• Muzammil S, Armstrong AA, Kang LW, et al. Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations. J Virol 2007;81:5144–54.
   PubMed Web of Science ®Google Scholar
• Li S-Y, Jiang N, Xie S-S, et al. Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease. Org Biomol Chem 2014;12:801–14.
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Tsuchiya Y, Sugumi H, et al. Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives. J Med Chem 1990;33:1880–7.
   PubMed Web of Science ®Google Scholar
• Xie SS, Wang XB, Li JY, et al. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease. Eur J Med Chem 2013;64:540–53.
   PubMed Web of Science ®Google Scholar
• Bartolini M, Bertucci C, Bolognesi ML, et al. Insight into the kinetic of amyloid beta (1–42) peptide self-aggregation: elucidation of inhibitors' mechanism of action. Chembiochem 2007;8:2152–61.
   PubMed Web of Science ®Google Scholar
• Lu C, Guo Y, Yan J, et al. Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease. J Med Chem 2013;56:5843–59.
   PubMed Web of Science ®Google Scholar
• Miller NJ, Rice-Evans CA. Factors influencing the antioxidant activity determined by the ABTS.+ radical cation assay. Free Radic Res 1997;26:195–9.
   PubMed Web of Science ®Google Scholar
• Magliaro BC, Saldanha CJ. Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation. Brain Res 2009;1283:14–24.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, et al High throughput artificial membrane permeability assay for blood?brain barrier. Eur J Med Chem 2003;38:223–32.
   PubMed Web of Science ®Google Scholar
• Galdeano C, Viayna E, Sola, et al. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases. J Med Chem 2012;55:661–9.
   PubMed Web of Science ®Google Scholar